SofWave Medical Ltd. (SOFW.TA)
ILA 1675.0
(-1.47%)
ILA 1675.0
(-1.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 50.31 Million | 35.63 Million | 21.83 Million | 4.29 Million | 278 Thousand |
| Cost of Revenue | 12.83 Million | 9.29 Million | 5.6 Million | 1.66 Million | 97 Thousand |
| Gross Profit | 37.48 Million | 26.33 Million | 16.23 Million | 2.62 Million | 181 Thousand |
| Operating Expenses | 45.29 Million | 43.67 Million | 25.1 Million | 9.17 Million | 3.34 Million |
| Selling, General and Administrative Expenses | 14.11 Million | 11.08 Million | 5.68 Million | 2.21 Million | 503 Thousand |
| Research and Development Expenses | 11.42 Million | 12.44 Million | 8.23 Million | 4.58 Million | 2.63 Million |
| Other Expenses | 19.92 Million | - | - | - | - |
| Cost and Expenses | 58.3 Million | 52.96 Million | 30.7 Million | 10.84 Million | 3.44 Million |
| Operating Income | -7.99 Million | -17.33 Million | -8.86 Million | -6.55 Million | -3.16 Million |
| Interest Expense | - | 1.11 Million | 549 Thousand | 333 Thousand | 231 Thousand |
| Income Tax Expense | 16 Thousand | 321 Thousand | -321 Thousand | -99 Thousand | -152 Thousand |
| Earnings before Tax | -8.26 Million | -19.2 Million | -7.14 Million | -11.68 Million | -3.44 Million |
| Net Income | -8.27 Million | -19.52 Million | -6.82 Million | -11.68 Million | -3.44 Million |
| Earnings Per Share Basic | -0.24 | -0.57 | -0.29 | -0.35 | -0.10 |
| Earnings Per Share Diluted | -0.24 | -0.57 | -0.29 | -0.34 | -0.10 |
| Weighted Average Shares Outstanding | 34.15 Million | 34.07 Million | 23.49 Million | 33.74 Million | 34.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.15 Million | 34.07 Million | 23.49 Million | 34.29 Million | 34.29 Million |
| Gross Margin | 0.74 | 0.74 | 0.74 | 0.61 | 0.65 |
| EBIT Margin | -0.13 | -0.48 | -0.39 | -1.53 | -11.86 |
| Profit Margin | -0.16 | -0.55 | -0.31 | -2.72 | -12.39 |
| EBITDA | -6.61 Million | -16.97 Million | -8.49 Million | -11.32 Million | -3.19 Million |
| Earnings Before Tax Margin | -0.16 | -0.49 | -0.41 | -1.53 | -11.37 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.64 Million | 13.18 Million | 50.31 Million | 15.3 Million | 12.22 Million | 12.38 Million |
| Cost of Revenue | 3.49 Million | 3.27 Million | 12.83 Million | 3.83 Million | 3.3 Million | 3.14 Million |
| Gross Profit | 11.14 Million | 9.91 Million | 37.48 Million | 11.47 Million | 8.92 Million | 9.23 Million |
| Operating Expenses | 12.36 Million | 10.87 Million | 45.47 Million | 12.62 Million | 10.13 Million | 12.11 Million |
| Selling, General and Administrative Expenses | 9.67 Million | 8.22 Million | - | 9.02 Million | 7.6 Million | 8.98 Million |
| Research and Development Expenses | 2.68 Million | 2.64 Million | - | 2.78 Million | 2.52 Million | 3.13 Million |
| Other Expenses | -2.42 Million | - | - | - | - | - |
| Cost and Expenses | 15.85 Million | 14.14 Million | 58.3 Million | 16.45 Million | 13.43 Million | 15.25 Million |
| Operating Income | -1.21 Million | -957 Thousand | -7.99 Million | -164 Thousand | -1.21 Million | -2.87 Million |
| Interest Expense | 265 Thousand | 296 Thousand | 144 Thousand | - | - | 336 Thousand |
| Income Tax Expense | 213 Thousand | 30 Thousand | 16 Thousand | 16 Thousand | - | 381 Thousand |
| Earnings before Tax | -1.31 Million | -953 Thousand | -8.26 Million | -359 Thousand | -1.23 Million | -2.83 Million |
| Net Income | -1.53 Million | -983 Thousand | -8.27 Million | -375 Thousand | -1.23 Million | -2.83 Million |
| Earnings Per Share Basic | -0.04 | -0.03 | - | -0.01 | -0.04 | -0.08 |
| Earnings Per Share Diluted | -0.04 | -0.03 | - | -0.01 | -0.04 | -0.08 |
| Weighted Average Shares Outstanding | 34.32 Million | 34.18 Million | 34.15 Million | 34.16 Million | 34.15 Million | 34.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.32 Million | 34.18 Million | 34.15 Million | 34.16 Million | 34.15 Million | 34.15 Million |
| Gross Margin | 0.76 | 0.75 | 0.74 | 0.75 | 0.73 | 0.75 |
| EBIT Margin | -0.04 | -0.02 | - | 0.00 | -0.07 | -0.17 |
| Profit Margin | -0.10 | -0.07 | -0.16 | -0.02 | -0.10 | -0.23 |
| EBITDA | -655 Thousand | -251 Thousand | - | 51 Thousand | -879 Thousand | -2.15 Million |
| Earnings Before Tax Margin | -0.08 | -0.07 | -0.16 | -0.01 | -0.10 | -0.23 |
DELT
7709
IRIS
MGRO
ALRGR
EXPLEOSOL